Literature DB >> 20359851

Are treatment options related to alexithymia in eating disorders? Results from a three-year naturalistic longitudinal study.

Mario Speranza1, Gwenolé Loas, Olivier Guilbaud, Maurice Corcos.   

Abstract

OBJECTIVE: Longitudinal studies have shown that alexithymic features can interfere with treatment response in eating disorders. However, an alternative hypothesis could be that clinicians faced with alexithymic patients chose different treatment options according to their perceptions of these patients. The aim of this investigation was to explore the relationships between alexithymic features and treatment options provided by professionals in a naturalistic prospective study of eating disorders.
METHODS: We conducted a 3-year longitudinal study exploring a sample of 102 DSM-IV Eating Disorder patients with the Toronto Alexithymia Scale (TAS-20). All treatments received during follow-up were recorded and recoded dichotomously, and crossed with the variation of alexithymic categories (cut-off≥56) between inclusion and follow-up.
RESULTS: Patients received different treatments according to their alexithymic profile, in terms both of number and type of treatment received. Patients with high, stable levels of alexithymia received overall more treatments, and significantly more antidepressants, than non-alexithymic patients. Patients who became alexithymics during follow-up were more often rehospitalized and received fewer regular psychotherapies than the non-alexithymic patients.
CONCLUSIONS: Professionals should carefully monitor these personality features and be aware of the potential impact of alexithymic features on treatment compliance and on treatment choice for eating disordered patients.
Copyright © 2010 Elsevier Masson SAS. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20359851     DOI: 10.1016/j.biopha.2010.01.009

Source DB:  PubMed          Journal:  Biomed Pharmacother        ISSN: 0753-3322            Impact factor:   6.529


  8 in total

Review 1.  Alexithymia in eating disorders: therapeutic implications.

Authors:  Federica Pinna; Lucia Sanna; Bernardo Carpiniello
Journal:  Psychol Res Behav Manag       Date:  2014-12-22

Review 2.  Alexithymia in eating disorders: Systematic review and meta-analyses of studies using the Toronto Alexithymia Scale.

Authors:  Heather Westwood; Jess Kerr-Gaffney; Daniel Stahl; Kate Tchanturia
Journal:  J Psychosom Res       Date:  2017-06-11       Impact factor: 3.006

Review 3.  Physiological, emotional and neural responses to visual stimuli in eating disorders: a review.

Authors:  Victoria Burmester; Esme Graham; Dasha Nicholls
Journal:  J Eat Disord       Date:  2021-02-17

4.  Alexithymia Is Associated With Deficits in Visual Search for Emotional Faces in Clinical Depression.

Authors:  Thomas Suslow; Vivien Günther; Tilman Hensch; Anette Kersting; Charlott Maria Bodenschatz
Journal:  Front Psychiatry       Date:  2021-06-29       Impact factor: 4.157

5.  Psychosomatic syndromes and anorexia nervosa.

Authors:  Giovanni Abbate-Daga; Nadia Delsedime; Barbara Nicotra; Cristina Giovannone; Enrica Marzola; Federico Amianto; Secondo Fassino
Journal:  BMC Psychiatry       Date:  2013-01-09       Impact factor: 3.630

6.  Alexithymia as a prognostic risk factor for health problems: a brief review of epidemiological studies.

Authors:  Masayo Kojima
Journal:  Biopsychosoc Med       Date:  2012-12-17

7.  Explicit and Implicit Responses of Seeing Own vs. Others' Emotions: An Electromyographic Study on the Neurophysiological and Cognitive Basis of the Self-Mirroring Technique.

Authors:  Alessandra Vergallito; Giulia Mattavelli; Emanuele Lo Gerfo; Stefano Anzani; Viola Rovagnati; Maurizio Speciale; Piergiuseppe Vinai; Paolo Vinai; Luisa Vinai; Leonor J Romero Lauro
Journal:  Front Psychol       Date:  2020-03-31

8.  The Impact of Alexithymia on Treatment Response in Psychiatric Disorders: A Systematic Review.

Authors:  Federica Pinna; Mirko Manchia; Pasquale Paribello; Bernardo Carpiniello
Journal:  Front Psychiatry       Date:  2020-04-16       Impact factor: 4.157

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.